HNSN Arquivamentos da SEC - Hansen Medical, Inc.- Relatório Anual, Declaração de Procuração, Prospecto

Estatísticas Básicas

CIK

1276591

SEC Filings

All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis. These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to Hansen Medical, Inc.

SEC Filings (Chronological Order)

Esta página fornece uma lista completa e cronológica de Arquivamentos da SEC, excluindo os arquivamentos de propriedade que fornecemos em outro lugar.

August 8, 2016	15-12B	Hansen Medical 15-12B 15-12B UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 15 CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. Commission File Number 001-33151 Hansen Medical, Inc. (Exact name of registrant as specified
August 8, 2016	SC 13D/A	HNSN / Hansen Medical, Inc. / AURIS SURGICAL ROBOTICS, INC. - SC 13D/A Activist Investment SC 13D/A SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13D UNDER THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No. 1)* Hansen Medical, Inc. (Name of Issuer) Common Stock, $0.001 par value per share (Title of Class of Securities) 411307101 (CUSIP Number) Auris Surgical Robotics, Inc. 125 Shoreway Road, Suite D San Carlos, California 94070 (650) 610-0750 (Name, Address and Tele
July 27, 2016	S-8 POS	Hansen Medical S-8 POS S-8 POS As filed with the Securities and Exchange Commission on July 27, 2016 Registration No.
July 27, 2016	S-8 POS	Hansen Medical S-8 POS S-8 POS As filed with the Securities and Exchange Commission on July 27, 2016 Registration No.
July 27, 2016	S-8 POS	Hansen Medical S-8 POS S-8 POS As filed with the Securities and Exchange Commission on July 27, 2016 Registration No.
July 27, 2016	S-8 POS	Hansen Medical S-8 POS S-8 POS As filed with the Securities and Exchange Commission on July 27, 2016 Registration No.
July 27, 2016	S-8 POS	Hansen Medical S-8 POS S-8 POS As filed with the Securities and Exchange Commission on July 27, 2016 Registration No.
July 27, 2016	S-8 POS	Hansen Medical S-8 POS S-8 POS As filed with the Securities and Exchange Commission on July 27, 2016 Registration No.
July 27, 2016	S-8 POS	Hansen Medical S-8 POS S-8 POS 1 d230531ds8pos.htm S-8 POS As filed with the Securities and Exchange Commission on July 27, 2016 Registration No. 333-138969 Registration No. 333-143320 Registration No. 333-150606 Registration No. 333-159088 Registration No. 333-168671 Registration No. 333-172848 Registration No. 333-178931 Registration No. 333-187342 Registration No. 333-194545 Registration No. 333-202838 Registration N
July 27, 2016	S-8 POS	Hansen Medical S-8 POS S-8 POS 1 d230531ds8pos.htm S-8 POS As filed with the Securities and Exchange Commission on July 27, 2016 Registration No. 333-138969 Registration No. 333-143320 Registration No. 333-150606 Registration No. 333-159088 Registration No. 333-168671 Registration No. 333-172848 Registration No. 333-178931 Registration No. 333-187342 Registration No. 333-194545 Registration No. 333-202838 Registration N
July 27, 2016	S-8 POS	Hansen Medical S-8 POS S-8 POS As filed with the Securities and Exchange Commission on July 27, 2016 Registration No.
July 27, 2016	S-8 POS	Hansen Medical S-8 POS S-8 POS 1 d230531ds8pos.htm S-8 POS As filed with the Securities and Exchange Commission on July 27, 2016 Registration No. 333-138969 Registration No. 333-143320 Registration No. 333-150606 Registration No. 333-159088 Registration No. 333-168671 Registration No. 333-172848 Registration No. 333-178931 Registration No. 333-187342 Registration No. 333-194545 Registration No. 333-202838 Registration N
July 27, 2016	S-8 POS	Hansen Medical S-8 POS S-8 POS As filed with the Securities and Exchange Commission on July 27, 2016 Registration No.
July 27, 2016	EX-3.2	EX-3.2 EX-3.2 3 exhibit2.htm EX-3.2 HANSEN MEDICAL, INC. AMENDED AND RESTATED BYLAWS ARTICLE I Offices Section 1. The registered office shall be in the City of Wilmington, County of New Castle, State of Delaware. Section 2. The corporation may also have offices at such other places both within and without the State of Delaware as the board of directors may from time to time determine or the business of t
July 27, 2016	EX-3.1	AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF HANSEN MEDICAL, INC. * * * * * * ARTICLE I EX-3.1 AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF HANSEN MEDICAL, INC. * * * * * * ARTICLE I The name of this corporation is Hansen Medical, Inc. (the ?Corporation?). ARTICLE II The address of the registered office of the Corporation in the State of Delaware is 1209 Orange Street, Wilmington, County of New Castle, Delaware 19801. The name of its registered agent in the State of Delaware
July 27, 2016	8-K	Changes in Control of Registrant, Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Termination of a Material Definitive Agreement, Material Modification to Rights of Security Holders, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Financial Statements and Exhibits, Completion of Acquisition or Disposition of Assets, Submission of Matters to a Vote of Security Holders Hansen Medical, Inc. (Form: 8-K) UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): July 22, 2016 Hansen Medical, Inc. (Exact name of registrant as specified in its charter) Delaware 001-33151 14-1850535 (State or other jurisdiction (
June 20, 2016	DEFM14A	Hansen Medical DEFM14A DEFM14A Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.
June 20, 2016	CORRESP	Hansen Medical ESP CORRESP Hansen Medical, Inc. 800 East Middlefield Road Mountain View, California 94043 June 20, 2016 Via E-mail and EDGAR Ms. Amanda Ravitz Assistant Director Office of Electronics and Machinery Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 RE: Hansen Medical, Inc. Preliminary Proxy Statement on Schedule 14A Filed May 26, 2016 File No.
June 17, 2016	LETTER	LETTER Mail Stop 3030 June 17, 2016 Via E-mail Cary Vance President and Chief Executive Officer Hansen Medical, Inc.
June 14, 2016	CORRESP	Hansen Medical ESP CORRESP SIDLEY AUSTIN LLP 1001 PAGE MILL ROAD BUILDING 1 PALO ALTO, CA 94304 +1 650 565 7000 +1 650 565 7100 FAX BEIJING BOSTON BRUSSELS CENTURY CITY CHICAGO DALLAS GENEVA HONG KONG HOUSTON LONDON LOS ANGELES MUNICH NEW YORK PALO ALTO SAN FRANCISCO SHANGHAI SINGAPORE SYDNEY TOKYO WASHINGTON, D.
June 10, 2016	LETTER	LETTER Mail Stop 3030 June 10, 2016 Via E-mail Cary Vance President and Chief Executive Officer Hansen Medical, Inc.
May 31, 2016	SD	Hansen Medical SD SD UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM SD Specialized Disclosure Report HANSEN MEDICAL, INC.
May 31, 2016	EX-1.01	HANSEN MEDICAL, INC. CONFLICT MINERALS REPORT DATED: MAY 31, 2016 EX-1.01 Exhibit 1.01 HANSEN MEDICAL, INC. CONFLICT MINERALS REPORT DATED: MAY 31, 2016 INTRODUCTION This conflict minerals report (this ?Report?) has been prepared by Hansen Medical, Inc. (the ?Company?) in accordance with Rule 13p-1 (?Rule 13p-1?) under the Securities Exchange Act of 1934 (the ?1934 Act?). Please refer to Rule 13p-1, Form SD and the 1934 Act Release No. 34-67716 for definitions t
May 26, 2016	PREM14A	Hansen Medical PREM14A PREM14A Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.
May 16, 2016	10-Q	Hansen Medical 10-Q (Quarterly Report) 10-Q 1 hnsn-20160331x10q.htm 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2016 or ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commissio
May 13, 2016	S-8	Hansen Medical S-8 SEC Document As filed with the Securities and Exchange Commission on May 13, 2016 Registration No.
April 29, 2016	10-K/A	Hansen Medical 10-K/A (Annual Report) 10-K/A 1 hnsn-20151231x10ka.htm 10-K/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K/A (Amendment No. 1) x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2015 ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 From the transition period from to Co
April 29, 2016	SC 13D	HNSN / Hansen Medical, Inc. / AURIS SURGICAL ROBOTICS, INC. - SC 13D Activist Investment SC 13D SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13D UNDER THE SECURITIES EXCHANGE ACT OF 1934 Hansen Medical, Inc. (Name of Issuer) Common Stock, $0.0001 par value per share (Title of Class of Securities) 411307101 (CUSIP Number) Auris Surgical Robotics, Inc. 125 Shoreway Road, Suite D San Carlos, California 94070 (650) 610-0750 (Name, Address and Telephone Number of Pers
April 25, 2016	SC 13D	HNSN / Hansen Medical, Inc. / Westwood SPV LLC - SC 13D Activist Investment SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934* Hansen Medical, Inc. (Name of Issuer) Common Stock, Par Value $0.0001 Per Share (Title of Class of Securities) 411307101 (CUSIP Number) Lawrence T. Kennedy, Jr. c/o Westwood SPV LLC 1700 Madison Road, Suite 200 Cincinnati, OH 45206 (513) 729-9660 (Name, Address and Telephone Number of
April 23, 2016	10-K	Hansen Medical 10-K (Annual Report) 10-K 1 hnsn-20151231x10k.htm 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2015 ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 From the transition period from to Commission file number: 001
April 22, 2016	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits Hansen Medical, Inc. (Form: 8-K) UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): April 18, 2016 Hansen Medical, Inc. (Exact name of registrant as specified in its charter) Delaware 001-33151 14-1850535 (State or other jurisdiction
April 22, 2016	EX-10.1	RETENTION AGREEMENT EX-10.1 RETENTION AGREEMENT This Retention Agreement (the Agreement) is entered into as of April 18, 2016 (the Effective Date), by and between Christopher P. Lowe (Employee) and Hansen Medical, Inc. (the Corporation). AGREEMENT In consideration of the promises and mutual covenants set forth herein, the parties hereby agree as follows: 1. Definitions. As used in this Agreement, unless the c
April 22, 2016	SC 13D/A	HNSN / Hansen Medical, Inc. / FEINBERG LARRY N - AMENDMENT NO. 4 Activist Investment SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D/A Under the Securities Exchange Act of 1934* (Amendment No. 4) Hansen Medical, Inc. (Name of Issuer) Common Stock, Par Value $0.0001 Per Share (Title of Class of Securities) 411307101 (CUSIP Number) Larry N. Feinberg c/o Oracle Investment Management, Inc. 200 Greenwich Avenue Greenwich, CT 06830 (203) 862-7900 (Name, Address an
April 22, 2016	SC 13D/A	HNSN / Hansen Medical, Inc. / Jack W. Schuler Living Trust - AMENDMENT NO. 3 Activist Investment SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D/A Under the Securities Exchange Act of 1934* (Amendment No. 3) Hansen Medical, Inc. (Name of Issuer) Common Stock, Par Value $0.0001 Per Share (Title of Class of Securities) 411307101 (CUSIP Number) Jack W. Schuler Living Trust c/o Crabtree Partners LLC 100 N Field Drive STE 360 Lake Forest, Illinois 60045 (224) 880-1210 (Name,
April 20, 2016	EX-2.1	AGREEMENT AND PLAN OF MERGER among AURIS SURGICAL ROBOTICS, INC., PINECO ACQUISITION CORP. and HANSEN MEDICAL, INC. Dated as of April 19, 2016 TABLE OF CONTENTS ARTICLE I THE MERGER Section 1.01 Section 1.02 Section 1.03 Section 1.04 The Merger Closi EX-2.1 AGREEMENT AND PLAN OF MERGER among AURIS SURGICAL ROBOTICS, INC., PINECO ACQUISITION CORP. and HANSEN MEDICAL, INC. Dated as of April 19, 2016 TABLE OF CONTENTS ARTICLE I THE MERGER Section 1.01 Section 1.02 Section 1.03 Section 1.04 The Merger Closing Effective Time Organizational Documents, Directors and Officers of the Surviving Corporation ARTICLE II EFFECT OF THE MERGER ON CAPITAL STOC
April 20, 2016	8-K	Entry into a Material Definitive Agreement, Financial Statements and Exhibits, Other Events 8-K 1 htm53384.htm LIVE FILING UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): April 19, 2016 Hansen Medical, Inc. (Exact name of registrant as specified in its charter) Delaware 001-33151 14-1850535 (State or other jurisdiction (C
April 20, 2016	EX-99.1	Auris Surgical Robotics Agrees to Acquire Hansen Medical EX-99.1
April 20, 2016	EX-4.1	EX-4.1 EX-4.1 3 exhibit2.htm EX-4.1 VOTING AGREEMENT This Voting Agreement (this “Agreement”) dated as of April 19, 2016, is entered into by the undersigned (the “Stockholder”) in favor of and for the benefit of Auris Surgical Robotics, Inc., a Delaware corporation (“Parent”), Pineco Acquisition Corp., a Delaware corporation and a wholly owned subsidiary of Parent (“Sub”), and Hansen Medical, Inc., a Del
April 20, 2016	EX-10.1	EX-10.1 EX-10.1
April 20, 2016	EX-4.1	EX-4.1 EX-4.1
April 20, 2016	DEFA14A	Hansen Medical LIVE FILING Hansen Medical, Inc. (Form: 8-K) UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): April 19, 2016 Hansen Medical, Inc. (Exact name of registrant as specified in its charter) Delaware 001-33151 14-1850535 (State or other jurisdiction
April 20, 2016	EX-2.1	AGREEMENT AND PLAN OF MERGER among AURIS SURGICAL ROBOTICS, INC., PINECO ACQUISITION CORP. and HANSEN MEDICAL, INC. Dated as of April 19, 2016 TABLE OF CONTENTS ARTICLE I THE MERGER Section 1.01 Section 1.02 Section 1.03 Section 1.04 The Merger Closi EX-2.1 AGREEMENT AND PLAN OF MERGER among AURIS SURGICAL ROBOTICS, INC., PINECO ACQUISITION CORP. and HANSEN MEDICAL, INC. Dated as of April 19, 2016 TABLE OF CONTENTS ARTICLE I THE MERGER Section 1.01 Section 1.02 Section 1.03 Section 1.04 The Merger Closing Effective Time Organizational Documents, Directors and Officers of the Surviving Corporation ARTICLE II EFFECT OF THE MERGER ON CAPITAL STOC
April 20, 2016	EX-99.1	EX-99.1 EX-99.1
April 20, 2016	EX-10.1	EX-10.1 EX-10.1
April 6, 2016	8-K	Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Financial Statements and Exhibits Hansen Medical, Inc. (Form: 8-K) UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): March 31, 2016 Hansen Medical, Inc. (Exact name of registrant as specified in its charter) Delaware 001-33151 14-1850535 (State or other jurisdiction
April 6, 2016	EX-99.1	Hansen Medical, Inc. Receives NASDAQ Letter Regarding Late EX-99.1 Hansen Medical, Inc. Receives NASDAQ Letter Regarding Late Form 10-K Filing MOUNTAIN VIEW, CA (Marketwired) 04/06/16 Hansen Medical, Inc. (NASDAQ: HNSN) today announced that it received a notification letter on March 31, 2016 from The NASDAQ Stock Market (NASDAQ). The notification letter stated that because the Company has not yet filed its Annual Report on Form 10-K for the year e
April 1, 2016	10-Q/A	Hansen Medical AMENDMENT NO. 1 TO FORM 10-Q (Quarterly Report) 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (AMENDMENT NO. 1) (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2015 or ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File
April 1, 2016	10-Q/A	Hansen Medical AMENDMENT NO. 1 TO FORM 10-Q (Quarterly Report) 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (AMENDMENT NO. 1) (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2015 or ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Numbe
March 31, 2016	8-K	Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review 8-K 1 hansen8krestatedfinancials.htm HANSEN FORM 8-K RESTATED FINANCIALS UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES AND EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): March 25, 2016 HANSEN MEDICAL, INC. (Exact name of registrant as specified in its charter) Delaware 001-3315
March 15, 2016	NT 10-K	Hansen Medical FORM 12B-25 NT 10-K 1 a2016form12b-25.htm FORM 12B-25 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING SEC FILE NUMBER: 001-33151 CUSIP NUMBER: 411307200 (Check One): x Form 10-K ¨ Form 20-F ¨ Form 11-K ¨ Form 10-Q ¨ Form 10-D ¨ Form N-SAR ¨ Form N-CSR For Period Ended: December 31, 2015 ¨ Transition Report on Form 10-K ¨ Transition Report on Form
March 9, 2016	8-K/A	Hansen Medical LIVE FILING (Current Report/Significant Event) Hansen Medical, Inc. (Form: 8-K/A) UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K/A (Amendment No. 1) CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): March 9, 2016 Hansen Medical, Inc. (Exact name of registrant as specified in its charter) Delaware 001-33151 14-1850535 (State o
March 9, 2016	EX-10.1	February 29, 2016 EX-10.1 2 exhibit1.htm EX-10.1 February 29, 2016 Joe Guido 135 Santa Paula Avenue, San Francisco, CA 94127 Dear Joe: In connection with your voluntary resignation from employment yesterday, this letter (the “Agreement”) confirms the agreement between you and Hansen Medical, Inc. (the “Company”) regarding your separation of employment from the Company. 1. Termination Date. The termination of your e
February 24, 2016	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): February 18, 2016 Hansen Medical, Inc. (Exact name of registrant as specified in its charter) Delaware 001-33151 14-1850535 (State or other jurisdiction (Commission (I.R.S. Employer o
February 16, 2016	EX-1	JOINT FILING AGREEMENT EX-1 2 hansenmedical13ga2016ex1.htm JOINT FILING AGREEMENT EXHIBIT 1 JOINT FILING AGREEMENT This Joint Filing Agreement dated February 16, 2016 is by and between Birchview Capital, LP, a Delaware limited partnership, and Matthew Strobeck, an individual (the foregoing are collectively referred to herein as the "Filers"). Each of the Filers may be required to file with the United States Securities a
February 16, 2016	SC 13G/A	HNSN / Hansen Medical, Inc. / Birchview Capital, LP Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1) Hansen Medical, Inc. (Name of Issuer) Common Stock $0.0001 par value (Title of Class of Securities) 411307101 (CUSIP Number) December 31, 2015 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant
January 14, 2016	EX-99.1	Hansen Medical Announces Exploration of Strategic Alternatives EX-99.1 Hansen Medical Announces Exploration of Strategic Alternatives MOUNTAIN VIEW, CA (Marketwired) January 14, 2016- Hansen Medical, Inc. (NASDAQ: HNSN), the global leader in intravascular robotics, announced today that its board of directors has entered a process to explore strategic alternatives for the company focused on enhancing stockholder value, including, but not limited to, a licens
January 14, 2016	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits, Other Events 8-K 1 htm52975.htm LIVE FILING UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): January 8, 2016 Hansen Medical, Inc. (Exact name of registrant as specified in its charter) Delaware 001-33151 14-1850535 (State or other jurisdiction (
December 21, 2015	EX-10.2	EX-10.2 EX-10.2 3 exhibit2.htm EX-10.2 M U L T I – T E N A N T C O M M E R C I A L / I N D U S T R I A L L E A S E ( N N N ) SILICON VALLEY RESEARCH CENTER SAN JOSE, CALIFORNIA LANDLORD: LBA REALTY FUND II-WBP VII, INC., an Arizona corporation TENANT: HANSEN MEDICAL, INC., a Delaware corporation TABLE OF CONTENTS Page EXHIBITS: Exhibit A Exhibit B Exhibit C Exhibit D Exhibit E Exhibit F Exhibit G Exhibit
December 21, 2015	8-K	Hansen Medical LIVE FILING (Current Report/Significant Event) Hansen Medical, Inc. (Form: 8-K) UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): December 15, 2015 Hansen Medical, Inc. (Exact name of registrant as specified in its charter) Delaware 001-33151 14-1850535 (State or other jurisdicti
December 21, 2015	EX-10.1	LEASE TERMINATION AGREEMENT EX-10.1 LEASE TERMINATION AGREEMENT THIS LEASE TERMINATION AGREEMENT (Termination Agreement) is made as of the 15th day of December 2015 by and between Google Inc., a Delaware corporation, successor-in-interest to the property owned by BXP Research Park LLC, a Delaware limited liability company, successor in interest to MTV Research, LLC, a Delaware limited liability company (Landlord) and Han
December 21, 2015	EX-10.1	LEASE TERMINATION AGREEMENT EX-10.1 LEASE TERMINATION AGREEMENT THIS LEASE TERMINATION AGREEMENT (?Termination Agreement?) is made as of the 15th day of December 2015 by and between Google Inc., a Delaware corporation, successor-in-interest to the property owned by BXP Research Park LLC, a Delaware limited liability company, successor in interest to MTV Research, LLC, a Delaware limited liability company (?Landlord?) and Han
November 19, 2015	EX-10.1	November 6, 2015 EX-10.1 2 exhibit1.htm EX-10.1 November 6, 2015 Will Sutton 18819 Kingswood Terrace Minnetonka, MN 55345 Dear Will: This letter (the “Agreement”) confirms the agreement between you and Hansen Medical, Inc. (the “Company”) regarding your separation of employment from the Company. 1. Termination Date. Your employment with the Company terminated by voluntary resignation on November 6, 2015 (the “Term
November 19, 2015	8-K/A	Hansen Medical LIVE FILING (Current Report/Significant Event) Hansen Medical, Inc. (Form: 8-K/A) UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K/A (Amendment No. 1) CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): November 14, 2015 Hansen Medical, Inc. (Exact name of registrant as specified in its charter) Delaware 001-33151 14-1850535 (Sta
November 5, 2015	EX-99.1	Hansen Medical Reports Third Quarter 2015 Results and Business Update EX-99.1 2 hnsn-201509x30xex99x1.htm EXHIBIT 99.1 Exhibit 99.1 Hansen Medical Reports Third Quarter 2015 Results and Business Update MOUNTAIN VIEW, CA – November 5, 2015 – Hansen Medical, Inc. (NASDAQ: HNSN), the global leader in intravascular robotics, today reported recent business highlights and financial results for the third quarter ended September 30, 2015. Recent Business Highlights: • The C
November 5, 2015	8-K	Hansen Medical 8-K (Current Report/Significant Event) 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES AND EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): November 5, 2015 HANSEN MEDICAL, INC.
October 30, 2015	8-K	Hansen Medical LIVE FILING (Current Report/Significant Event) Hansen Medical, Inc. (Form: 8-K) UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): October 26, 2015 Hansen Medical, Inc. (Exact name of registrant as specified in its charter) Delaware 001-33151 14-1850535 (State or other jurisdictio
October 7, 2015	CT ORDER	Hansen Medical RDER UNITED STATES SECURITIES AND EXCHANGE COMMISSION October 7, 2015 ORDER GRANTING CONFIDENTIAL TREATMENT UNDER THE SECURITIES EXCHANGE ACT OF 1934 Hansen Medical, Inc.
September 23, 2015	8-K	Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): September 22, 2015 Hansen Medical, Inc. (Exact name of registrant as specified in its charter) Delaware 001-33151 14-1850535 (State or other jurisdiction (Commission (I.R.S. Employer
September 23, 2015	EX-3.1	CERTIFICATE OF AMENDMENT OF THE AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF HANSEN MEDICAL, INC. EX-3.1 CERTIFICATE OF AMENDMENT OF THE AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF HANSEN MEDICAL, INC. Hansen Medical, Inc., a corporation organized and existing under the General Corporation Law of the State of Delaware, does hereby certify as follows: FIRST: The name of the corporation is Hansen Medical, Inc. SECOND: The date on which the Certificate of Incorporation of the Corporation
August 6, 2015	8-K	Hansen Medical FORM 8-K (Current Report/Significant Event) Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES AND EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): August 6, 2015 HANSEN MEDICAL, INC.
August 6, 2015	EX-99.1	Hansen Medical Reports Second Quarter 2015 Results and Business Update EX-99.1 Exhibit 99.1 Hansen Medical Reports Second Quarter 2015 Results and Business Update MOUNTAIN VIEW, CA ? August 6, 2015 ? Hansen Medical, Inc. (NASDAQ: HNSN), the global leader in intravascular robotics, today reported recent business highlights and financial results for the second quarter ended June 30, 2015. Recent Business Highlights: ? Two customers demonstrated further utility of the M
July 1, 2015	424B3	HANSEN MEDICAL, INC. 177,828,561 Shares of Common Stock 424B3 1 d942463d424b3.htm 424B3 Table of Contents Filed Pursuant to Rule 424(b)(3) Registration No. 333-205122 PROSPECTUS HANSEN MEDICAL, INC. 177,828,561 Shares of Common Stock This prospectus relates to the offer for sale by existing holders of our common stock named in this prospectus of 177,828,561 shares of our common stock, par value $0.0001 per share, which includes 55,094,915 outstanding s
June 30, 2015	CORRESP	Hansen Medical ESP CORRESP Hansen Medical, Inc. 800 East Middlefield Road Mountain View, CA 94043 June 30, 2015 VIA EDGAR Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Attn: Timothy Buckmiller Re: Registration Statement on Form S-3 (Registration No. 333-205122) Ladies and Gentlemen: This letter is being furnished by Hansen Medical, Inc. (the ?Company?) w
June 29, 2015	LETTER	LETTER June 29, 2015 Via E-mail Cary G. Vance President and Chief Executive Officer Hansen Medical, Inc. 800 East Middlefield Road, Mountain View, CA 94043 Re: Hansen Medical, Inc. Registration Statement on Form S-3 Filed June 19, 2015 File No. 333-205122 Dear Mr. Vance: This is to advise you that we have not reviewed and will not review your registration statement. We urge all persons who are responsibl
June 19, 2015	EX-3.4	CERTIFICATE OF AMENDMENT OF THE AMENDED AND RESTATED CERTIFICATE OF INCORPORATION HANSEN MEDICAL, INC. EX-3.4 Exhibit 3.4 CERTIFICATE OF AMENDMENT OF THE AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF HANSEN MEDICAL, INC. Hansen Medical, Inc., a corporation organized and existing under the General Corporation Law of the State of Delaware, does hereby certify as follows: FIRST: The name of the Corporation is Hansen Medical, Inc. SECOND: The date on which the Certificate of Incorporation of the
June 19, 2015	S-3	Hansen Medical FORM S-3 S-3 1 d942463ds3.htm FORM S-3 Table of Contents As filed with the Securities and Exchange Commission on June 19, 2015 Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 Form S-3 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 HANSEN MEDICAL, INC. (Exact name of registrant as specified in its charter) Delaware 14-1850535 (State or other jurisdiction
June 16, 2015	EX-99.1	Hansen Medical, Inc. Non-Plan Notice of Restricted Stock Unit Award EX-99.1 Hansen Medical, Inc. Non-Plan Notice of Restricted Stock Unit Award Hansen Medical, Inc. (the ?Company?) hereby grants to Recipient restricted stock units (or ?units?), representing shares of Common Stock of the Company on the following terms: Name of Recipient: Total Number of Units Granted: Date of Grant: Vesting Commencement Date: Cary Vance 238,494 March 17, 2015 May 23, 2014 Vesting S
June 16, 2015	EX-99.2	Hansen Medical, Inc. Non-Plan Notice of Restricted Stock Unit Award EX-99.2
June 16, 2015	8-K	Other Events 8-K 1 htm51997.htm LIVE FILING UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): June 12, 2015 Hansen Medical, Inc. (Exact name of registrant as specified in its charter) Delaware 001-33151 14-1850535 (State or other jurisdiction (Co
June 1, 2015	SD	Hansen Medical SD SD UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM SD Specialized Disclosure Report HANSEN MEDICAL, INC.
June 1, 2015	EX-1.01	HANSEN MEDICAL, INC. CONFLICT MINERALS REPORT EX-1.01 Exhibit 1.01 HANSEN MEDICAL, INC. CONFLICT MINERALS REPORT INTRODUCTION This conflict minerals report (this ?Report?) has been prepared by Hansen Medical, Inc. (the ?Company?) in accordance with Rule 13p-1 (?Rule 13p-1?) under the Securities Exchange Act of 1934 (the ?1934 Act?). Please refer to Rule 13p-1, Form SD and the 1934 Act Release No. 34-67716 for definitions to the terms used in
May 21, 2015	8-K	Submission of Matters to a Vote of Security Holders Hansen Medical, Inc. (Form: 8-K) UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): May 15, 2015 Hansen Medical, Inc. (Exact name of registrant as specified in its charter) Delaware 001-33151 14-1850535 (State or other jurisdiction (C
May 20, 2015	SC 13D/A	HNSN / Hansen Medical, Inc. / SCHULER JACK W - SC 13D/A Activist Investment SC 13D/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D/A Under the Securities Exchange Act of 1934 (Amendment No. 2)* Hansen Medical, Inc. (Name of Issuer) Common Stock, Par Value $0.0001 Per Share (Title of Class of Securities) 411307101 (CUSIP Number) Jack W. Schuler c/o Crabtree Partners LLC 100 N Field Drive STE 360 Lake Forest, Illinois 60045 (224) 880-1
May 19, 2015	SC 13D/A	HNSN / Hansen Medical, Inc. / FEINBERG LARRY N - AMENDMENT NO. 3 Activist Investment SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D/A Under the Securities Exchange Act of 1934* (Amendment No. 3) Hansen Medical, Inc. (Name of Issuer) Common Stock, Par Value $0.0001 Per Share (Title of Class of Securities) 411307101 (CUSIP Number) Larry N. Feinberg c/o Oracle Investment Management, Inc. 200 Greenwich Avenue Greenwich, CT 06830 (203) 862-7900 (Name, Address an
May 18, 2015	EX-99.2	Joint Filer Information and Signatures Designated Filer: FEINBERG LARRY N Issuer & Ticker Symbol: Hansen Medical, Inc. [HNSN] Date of Event Requiring Statement: May 12, 2015 Joint Filer Information and Signatures Joint Filers: 1. Name: Address: Oracle Partners, L.P. c/o Oracle Investment Management, Inc., 200 Greenwich Avenue, Greenwich CT 06830 ORACLE PARTNERS, L.P. By: ORACLE ASSOCIATES, LLC, its general partner By: /s/ Larry N. Fein
May 18, 2015	EX-99.1	Explanation of Responses Designated Filer: FEINBERG LARRY N Issuer & Ticker Symbol: Hansen Medical, Inc. [HNSN] Date of Event Requiring Statement: May 12, 2015 Explanation of Responses (1) These securities are owned by Oracle Partners, L.P. (? Oracle Partners?). (2) These securities are owned by Oracle Ten Fund Master, L.P. (? Oracle Ten Fund?). (3) These securities are owned by Oracle Institutional Partners, L.P. (? Inst
May 15, 2015	8-K	Other Events Hansen Medical, Inc. (Form: 8-K) UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): May 15, 2015 Hansen Medical, Inc. (Exact name of registrant as specified in its charter) Delaware 001-33151 14-1850535 (State or other jurisdiction (C
May 7, 2015	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition 8-K 1 d921937d8k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES AND EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): May 7, 2015 HANSEN MEDICAL, INC. (Exact name of registrant as specified in charter) Delaware 001-33151 14-1850535 (State or other jurisdiction of incor
May 7, 2015	EX-99.1	Hansen Medical Reports First Quarter 2015 Results and Business Update EX-99.1 Exhibit 99.1 Hansen Medical Reports First Quarter 2015 Results and Business Update MOUNTAIN VIEW, CA ? May 7, 2015 ? Hansen Medical, Inc. (NASDAQ: HNSN), the global leader in intravascular robotics, today reported recent business highlights and financial results for the first quarter ended March 31, 2015. First Quarter 2015 Operating Results: ? The Company reported revenues of $5.8 million
April 17, 2015	8-K	Hansen Medical LIVE FILING (Current Report/Significant Event) Hansen Medical, Inc. (Form: 8-K) UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): April 17, 2015 Hansen Medical, Inc. (Exact name of registrant as specified in its charter) Delaware 001-33151 14-1850535 (State or other jurisdiction
April 13, 2015	424B3	HANSEN MEDICAL, INC. 68,887,646 Shares of Common Stock 424B3 Table of Contents Filed Pursuant to Rule 424(b)(3) Registration No. 333-202837 PROSPECTUS HANSEN MEDICAL, INC. 68,887,646 Shares of Common Stock This prospectus relates to the offer for sale by existing holders of our common stock named in this prospectus of 68,887,646 shares of our common stock, par value $0.0001 per share, which includes 8,607,903 shares of our common stock issuable upon t
April 10, 2015	DEF 14A	Hansen Medical DEFINITIVE PROXY STATEMENT Definitive Proxy Statement Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.
March 27, 2015	PRE 14A	Hansen Medical PRELIMINARY PROXY STATEMENT Preliminary Proxy Statement Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.
March 26, 2015	SC 13D/A	HNSN / Hansen Medical, Inc. / SCHULER JACK W - SC 13D/A Activist Investment SC 13D/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D/A Under the Securities Exchange Act of 1934 (Amendment No. 1)* Hansen Medical, Inc. (Name of Issuer) Common Stock, Par Value $0.0001 Per Share (Title of Class of Securities) 411307101 (CUSIP Number) Jack W. Schuler c/o Crabtree Partners LLC 28161 North Keith Drive Lake Forest, Illinois 60045 (847) 607-206
March 19, 2015	EX-1	JOINT FILING AGREEMENT EXHIBIT 1 JOINT FILING AGREEMENT This Joint Filing Agreement dated March 19, 2015 is by and between Birchview Capital, LP, a Delaware limited partnership, and Matthew Strobeck, an individual (the foregoing are collectively referred to herein as the "Filers").
March 19, 2015	SC 13G	HNSN / Hansen Medical, Inc. / Birchview Capital, LP Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 Hansen Medical, Inc. (Name of Issuer) Common Stock $0.0001 par value (Title of Class of Securities) 411307101 (CUSIP Number) March 11, 2015 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedu
March 18, 2015	EX-99.5	HANSEN MEDICAL, INC. NOTICE OF RESTRICTED STOCK UNIT AWARD EX-99.5 Exhibit 99.5 HANSEN MEDICAL, INC. NON-PLAN NOTICE OF RESTRICTED STOCK UNIT AWARD Hansen Medical, Inc. (the ?Company?) hereby grants to Recipient restricted stock units (or ?units?), representing shares of Common Stock of the Company on the following terms: Name of Recipient: Cary Vance On-Target Units: 158,996 Maximum Number of Units: 238,494 (if maximum performance is achieved) Date of Gr
March 18, 2015	S-3	Hansen Medical S-3 S-3 1 d891310ds3.htm S-3 Table of Contents As filed with the Securities and Exchange Commission on March 17, 2015 Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 Form S-3 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 HANSEN MEDICAL, INC. (Exact name of registrant as specified in its charter) Delaware 14-1850535 (State or other jurisdiction of i
March 18, 2015	S-8	Hansen Medical S-8 S-8 1 d891305ds8.htm S-8 As filed with the Securities and Exchange Commission on March 17, 2015 Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-8 REGISTRATION STATEMENT Under The Securities Act of 1933 HANSEN MEDICAL, INC. (Exact name of registrant as specified in its charter) Delaware 14-1850535 (State or other jurisdiction of incorporation or
March 18, 2015	EX-99.4	HANSEN MEDICAL, INC. NOTICE OF RESTRICTED STOCK UNIT AWARD EX-99.4 5 d891305dex994.htm EX-99.4 Exhibit 99.4 HANSEN MEDICAL, INC. NON-PLAN NOTICE OF RESTRICTED STOCK UNIT AWARD Hansen Medical, Inc. (the “Company”) hereby grants to Recipient restricted stock units (or “units”), representing shares of Common Stock of the Company on the following terms: Name of Recipient: Cary Vance Total Number of Units Granted: 238,494 Date of Grant: March 17, 2015 Vesting
March 12, 2015	SC 13D/A	HNSN / Hansen Medical, Inc. / FEINBERG LARRY N - SCHEDULE 13D/A Activist Investment Schedule 13D/A SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D/A Under the Securities Exchange Act of 1934* (Amendment No. 2) Hansen Medical, Inc. (Name of Issuer) Common Stock, Par Value $0.0001 Per Share (Title of Class of Securities) 411307101 (CUSIP Number) Larry N. Feinberg c/o Oracle Investment Management, Inc. 200 Greenwich Avenue Greenwich, CT 06830 (203) 862-7900 (N
March 12, 2015	EX-1	SECURITIES PURCHASE AGREEMENT EX-1 Exhibit 1 Execution Version SECURITIES PURCHASE AGREEMENT This Securities Purchase Agreement (this Agreement) is dated as of March 9, 2015, between Hansen Medical, Inc.
March 12, 2015	8-K	Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits 8-K 1 d885930d8k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES AND EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): March 9, 2015 HANSEN MEDICAL, INC. (Exact name of registrant as specified in charter) Delaware 001-33151 14-1850535 (State or other jurisdiction of inc
March 12, 2015	EX-3.1	CERTIFICATE OF DESIGNATIONS, PREFERENCES AND RIGHTS OF SERIES A CONVERTIBLE PARTICIPATING PREFERRED STOCK HANSEN MEDICAL, INC. (Pursuant to Section 151 of the Delaware General Corporation Law) EX-3.1 2 d885930dex31.htm EX-3.1 Exhibit 3.1 Execution Version CERTIFICATE OF DESIGNATIONS, PREFERENCES AND RIGHTS OF SERIES A CONVERTIBLE PARTICIPATING PREFERRED STOCK OF HANSEN MEDICAL, INC. (Pursuant to Section 151 of the Delaware General Corporation Law) Hansen Medical, Inc., a Delaware corporation (the “Corporation”), hereby certifies that the following resolution was duly approved and adopte
March 12, 2015	EX-3	SECOND AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT EX-3 4 d887846dex3.htm EX-3 Exhibit 3 Execution Version SECOND AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT This SECOND AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT (the “Agreement”) is made as of March 11, 2015 by and among Hansen Medical, Inc., a corporation organized and existing under the laws of the State of Delaware (the “Company”), Oracle Partners, LP, Oracle Institutional Partners, LP
March 12, 2015	EX-4.2	HANSEN MEDICAL, INC. SERIES E WARRANT Warrant No. E-[—] Date of Issuance: March 11, 2015 EX-4.2 4 d885930dex42.htm EX-4.2 Exhibit 4.2 Execution Version NEITHER THIS WARRANT, NOR THE SECURITIES ISSUABLE UPON EXERCISE OF THIS WARRANT (COLLECTIVELY, THE “SECURITIES”), HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), OR UNDER ANY STATE SECURITIES OR BLUE SKY LAWS. THE SECURITIES ARE SUBJECT TO RESTRICTIONS ON TRANSFERABILITY AND RESALE AND MAY NOT
March 12, 2015	EX-2	HANSEN MEDICAL, INC. SERIES E WARRANT Warrant No. E-[—] Date of Issuance: March 11, 2015 EX-2 3 d887846dex2.htm EX-2 Exhibit 2 Execution Version NEITHER THIS WARRANT, NOR THE SECURITIES ISSUABLE UPON EXERCISE OF THIS WARRANT (COLLECTIVELY, THE “SECURITIES”), HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), OR UNDER ANY STATE SECURITIES OR BLUE SKY LAWS. THE SECURITIES ARE SUBJECT TO RESTRICTIONS ON TRANSFERABILITY AND RESALE AND MAY NOT BE OFFE
March 12, 2015	EX-4.1	SECURITIES PURCHASE AGREEMENT EX-4.1 Exhibit 4.1 Execution Version SECURITIES PURCHASE AGREEMENT This Securities Purchase Agreement (this ?Agreement?) is dated as of March 9, 2015, between Hansen Medical, Inc., a Delaware corporation (the ?Company?), and each purchaser identified on Exhibit A hereto (each, including its successors and assigns, a ?Purchaser? and collectively, the ?Purchasers?). WHEREAS, on the terms and subject
March 12, 2015	EX-4.3	SECOND AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT EX-4.3 Exhibit 4.3 Execution Version SECOND AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT This SECOND AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT (the ?Agreement?) is made as of March 11, 2015 by and among Hansen Medical, Inc., a corporation organized and existing under the laws of the State of Delaware (the ?Company?), Oracle Partners, LP, Oracle Institutional Partners, LP and Oracle Ten Fund
March 12, 2015	EX-4	CERTIFICATE OF DESIGNATIONS, PREFERENCES AND RIGHTS OF SERIES A CONVERTIBLE PARTICIPATING PREFERRED STOCK HANSEN MEDICAL, INC. (Pursuant to Section 151 of the Delaware General Corporation Law) EX-4 5 d887846dex4.htm EX-4 Exhibit 4 Execution Version CERTIFICATE OF DESIGNATIONS, PREFERENCES AND RIGHTS OF SERIES A CONVERTIBLE PARTICIPATING PREFERRED STOCK OF HANSEN MEDICAL, INC. (Pursuant to Section 151 of the Delaware General Corporation Law) Hansen Medical, Inc., a Delaware corporation (the “Corporation”), hereby certifies that the following resolution was duly approved and adopted by th
February 24, 2015	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES AND EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): February 23, 2015 HANSEN MEDICAL, INC.
February 24, 2015	EX-99.1	Hansen Medical Reports Fourth Quarter and Full-Year 2014 Results EX-99.1 Exhibit 99.1 Hansen Medical Reports Fourth Quarter and Full-Year 2014 Results MOUNTAIN VIEW, CA – February 23, 2015 – Hansen Medical, Inc. (NASDAQ: HNSN), a global leader in intravascular robotics, today reported recent business highlights and financial results for the fourth quarter and fiscal year ended December 31, 2014. Fourth Quarter 2014 and Fiscal Year 2014 Operating Results: • The
December 15, 2014	SC 13D/A	HNSN / Hansen Medical, Inc. / FEINBERG LARRY N - SCHEDULE 13D/A, AMENDMENT #1 Activist Investment SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D/A Under the Securities Exchange Act of 1934* (Amendment No. 1) Hansen Medical, Inc. (Name of Issuer) Common Stock, Par Value $0.0001 Per Share (Title of Class of Securities) 411307101 (CUSIP Number) Larry N. Feinberg c/o Oracle Investment Management, Inc. 200 Greenwich Avenue Greenwich, CT 06830 (203) 862-7900 (Name, Address an
December 2, 2014	8-K	Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES AND EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): December 1, 2014 HANSEN MEDICAL, INC.
November 6, 2014	EX-99.1	Hansen Medical Reports Third Quarter 2014 Operating Results and Recent Business Highlights EX-99.1 Exhibit 99.1 Hansen Medical Reports Third Quarter 2014 Operating Results and Recent Business Highlights MOUNTAIN VIEW, CA – November 6, 2014 – Hansen Medical, Inc. (NASDAQ: HNSN), a global leader in intravascular robotics, today reported recent business highlights and financial results for the third quarter of fiscal year 2014 ended September 30, 2014. Third Quarter 2014 Operating Results:
November 6, 2014	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition 8-K 1 d817890d8k.htm 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES AND EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): November 6, 2014 HANSEN MEDICAL, INC. (Exact name of registrant as specified in charter) Delaware 001-33151 14-1850535 (State or other jurisdiction of incor
October 27, 2014	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES AND EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): October 22, 2014 HANSEN MEDICAL, INC.
October 9, 2014	8-K	Financial Statements and Exhibits, Changes in Registrant's Certifying Accountant 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES AND EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): October 6, 2014 HANSEN MEDICAL, INC.
October 9, 2014	EX-16.1	October 9, 2014 EX-16.1 Exhibit 16.1 October 9, 2014 Securities and Exchange Commission 100 F Street, N.E. Washington, D.C. 20549-7561 Dear Sirs/Madams: We have read Item 4.01 of Hansen Medical, Inc.’s Form 8-K dated October 9, 2014, and have the following comments: 1. We agree with the statements made in Item 4.01 (a) in the Form 8-K. 2. We have no basis on which to agree or disagree with the statements made in
July 31, 2014	8-K	Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits, Results of Operations and Financial Condition Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES AND EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): July 30, 2014 HANSEN MEDICAL, INC.
July 31, 2014	EX-99.1	Hansen Medical Reports Second Quarter 2014 Results and $23 Million EX-99.1 Exhibit 99.1 Hansen Medical Reports Second Quarter 2014 Results and $23 Million Financing MOUNTAIN VIEW, CA – July 31, 2014 – Hansen Medical, Inc. (NASDAQ: HNSN), a global leader in intravascular robotics, today reported recent business highlights and financial results for the second quarter of fiscal year 2014 ended June 30, 2014. Second Quarter 2014 Highlights: • Revenues of $6.9 million
June 24, 2014	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers - FORM 8-K Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES AND EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): June 18, 2014 HANSEN MEDICAL, INC.
June 17, 2014	8-K/A	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers - FORM 8-K/A Form 8-K/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K/A CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES AND EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): June 11, 2014 HANSEN MEDICAL, INC.
June 10, 2014	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers - FORM 8-K Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES AND EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): June 10, 2014 HANSEN MEDICAL, INC.
May 30, 2014	SD	- FORM SD FORM SD UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM SD Specialized Disclosure Report HANSEN MEDICAL, INC.
May 30, 2014	EX-1.02	HANSEN MEDICAL, INC. CONFLICT MINERALS REPORT DATED: MAY 30, 2014 EX-1.02 Exhibit 1.02 HANSEN MEDICAL, INC. CONFLICT MINERALS REPORT DATED: MAY 30, 2014 INTRODUCTION This conflict minerals report (this “Report”) has been prepared by Hansen Medical, Inc. (the “Company”) in accordance with Rule 13p-1 (“Rule 13p-1”) under the Securities Exchange Act of 1934 (the “1934 Act”). Please refer to Rule 13p-1, Form SD and the 1934 Act Release No. 34-67716 for definitions t
May 14, 2014	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers - FORM 8-K Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES AND EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): May 9, 2014 HANSEN MEDICAL, INC.
May 7, 2014	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition - FORM 8-K Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES AND EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): May 7, 2014 HANSEN MEDICAL, INC.
May 7, 2014	EX-99.1	Hansen Medical Reports Recent Business Highlights and First Quarter 2014 Results EX-99.1 Exhibit 99.1 Hansen Medical Reports Recent Business Highlights and First Quarter 2014 Results MOUNTAIN VIEW, CA. – May 7, 2014 – Hansen Medical, Inc. (NASDAQ: HNSN), a global leader in intravascular robotics, today reported recent business highlights and financial results for the first quarter of fiscal year 2014 ended March 31, 2014. Recent Business Highlights: • Yesterday, the Company’s
May 6, 2014	EX-99.1	Hansen Medical Appoints Cary Vance as President and CEO EX-99.1 Exhibit 99.1 Hansen Medical Appoints Cary Vance as President and CEO MOUNTAIN VIEW, CA. — May 06, 2014 — Hansen Medical, Inc. (NASDAQ: HNSN), a global leader in intravascular robotics, today announced that its Board of Directors has appointed industry veteran Cary Vance as the Company’s President and Chief Executive Officer, and a member of the Board of Directors, effective as of May 23, 2
May 6, 2014	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits 8-K 1 d722946d8k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES AND EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): April 25, 2014 HANSEN MEDICAL, INC. (Exact name of registrant as specified in charter) Delaware 001-33151 14-1850535 (State or other jurisdiction of in
May 1, 2014	8-K	Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES AND EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): April 29, 2014 HANSEN MEDICAL, INC.
March 20, 2014	DEF 14A	- DEFINITIVE PROXY STATEMENT DEF 14A 1 d669597ddef14a.htm DEFINITIVE PROXY STATEMENT Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a Party other than the Registrant ¨ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confidential,
March 20, 2014	DEFA14A	- DEFINITIVE ADDITIONAL MATERIALS Definitive Additional Materials UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.
March 13, 2014	S-8	- FORM S-8 FORM S-8 As filed with the Securities and Exchange Commission on March 13, 2014 Registration No.
March 13, 2014	10-K	Hansen Medical FORM 10-K (Annual Report) Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2013 ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 From the transition period from to Commission file number: 001-33151 HANSEN ME
March 7, 2014	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 8-K 1 d686485d8k.htm 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES AND EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): March 3, 2014 HANSEN MEDICAL, INC. (Exact name of registrant as specified in charter) Delaware 001-33151 14-1850535 (State or other jurisdiction of incorpor
February 21, 2014	EX-10.1	HANSEN MEDICAL, INC. February 14, 2014 EX-10.1 2 d680475dex101.htm EX-10.1 Exhibit 10.1 HANSEN MEDICAL, INC. February 14, 2014 Christopher P. Lowe Via Email Dear Chris: Hansen Medical, Inc. (the “Company”) is pleased to confirm the terms of your employment as follows: 1. Position. Your title will be Interim Chief Executive Officer, and you will report to the Company’s Board of Directors. This is a full-time temporary position. While yo
February 21, 2014	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits - FORM 8-K Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES AND EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): February 14, 2014 HANSEN MEDICAL, INC.
February 20, 2014	EX-99.1	Hansen Medical Reports Fourth Quarter and Full-Year 2013 Results EX-99.1 2 d678106dex991.htm EX-99.1 Exhibit 99.1 Hansen Medical Reports Fourth Quarter and Full-Year 2013 Results MOUNTAIN VIEW, CA. – February 20, 2014 – Hansen Medical, Inc. (NASDAQ: HNSN), a global leader in intravascular robotics, today reported recent business highlights and financial results for the fourth quarter and full year ended December 31, 2013. Fourth Quarter and Fiscal Year 2013 Hig
February 20, 2014	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition, Other Events - FORM 8-K Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES AND EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): February 20, 2014 HANSEN MEDICAL, INC.
February 11, 2014	8-K	Financial Statements and Exhibits, Other Events - FORM 8-K Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES AND EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): February 10, 2014 HANSEN MEDICAL, INC.
February 11, 2014	EX-99.1	Hansen Medical Announces FDA Clearance of the Magellan™ 6Fr Robotic Catheter New Smaller Diameter Catheter Extends Clinical Benefits of Intravascular Robotics to Broader Set of Patients, Physicians and Procedures FDA Clearance Triggers the Mandatory EX-99.1 Exhibit 99.1 Hansen Medical Announces FDA Clearance of the Magellan™ 6Fr Robotic Catheter New Smaller Diameter Catheter Extends Clinical Benefits of Intravascular Robotics to Broader Set of Patients, Physicians and Procedures FDA Clearance Triggers the Mandatory Exercise of Approximately $14 million of Series A Warrants MOUNTAIN VIEW, CA. – February 11, 2014 – Hansen Medical, Inc. (Nasdaq:
February 10, 2014	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers - FORM 8-K Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES AND EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): February 9, 2014 HANSEN MEDICAL, INC.
January 23, 2014	SC 13G/A	HNSN / Hansen Medical, Inc. / ARASKOG RAND V - SC 13G/A Passive Investment SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G/A (Rule 13d-102) Under the Securities Exchange Act of 1934 (Amendment No. 3) Hansen Medical, Inc. (Name of Issuer) Common Stock (Title of Class of Securities) 411307101 (CUSIP Number) December 31, 2013 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this
January 13, 2014	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES AND EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): January 13, 2014 HANSEN MEDICAL, INC.
January 13, 2014	EX-99.1	Hansen Medical Reports Preliminary Fourth Quarter and Full-Year 2013 Results and Recent Business Highlights Company Meets Previously Communicated 2013 Outlook for Commercialization of Systems and Estimated Procedures Commercialized Six Robotic System EX-99.1 Exhibit 99.1 Hansen Medical Reports Preliminary Fourth Quarter and Full-Year 2013 Results and Recent Business Highlights Company Meets Previously Communicated 2013 Outlook for Commercialization of Systems and Estimated Procedures Commercialized Six Robotic Systems in the Quarter, Bringing Total Commercialized Systems For 2013 to 14 Physicians Performed an Estimated 815 Procedures in the Qu
December 11, 2013	8-K	Other Events Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities and Exchange Act of 1934 Date of report (Date of earliest event reported): December 5, 2013 HANSEN MEDICAL, INC.
November 27, 2013	424B3	HANSEN MEDICAL, INC. 62,601,623 Shares of Common Stock 424B3 Table of Contents Filed Pursuant to Rule 424(b)(3) Registration No. 333-192216 PROSPECTUS HANSEN MEDICAL, INC. 62,601,623 Shares of Common Stock This prospectus relates to the offer for sale by existing holders of our common stock named in this prospectus of 62,601,623 shares of our common stock, par value $0.0001 per share, which includes 34,146,339 shares of our common stock issuable upon
November 27, 2013	424B3	HANSEN MEDICAL, INC. 5,291,005 Shares of Common Stock Table of Contents Filed Pursuant to Rule 424(b)(3) Registration No. 333-192218 PROSPECTUS HANSEN MEDICAL, INC. 5,291,005 Shares of Common Stock This prospectus relates to the offer for sale by an existing holder of our common stock named in this prospectus of 5,291,005 shares of our common stock, par value $0.0001 per share. The existing holder of our common stock is referred to as the selling sto
November 26, 2013	8-K	Other Events - 8-K 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities and Exchange Act of 1934 Date of report (Date of earliest event reported): November 26, 2013 HANSEN MEDICAL, INC.
November 8, 2013	S-3	- S-3 S-3 1 d623184ds3.htm S-3 Table of Contents As filed with the Securities and Exchange Commission on November 8, 2013 Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 Form S-3 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 HANSEN MEDICAL, INC. (Exact name of registrant as specified in its charter) Delaware 14-1850535 (State or other jurisdiction of
November 8, 2013	S-3	- S-3 S-3 1 d623159ds3.htm S-3 Table of Contents As filed with the Securities and Exchange Commission on November 8, 2013 Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 Form S-3 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 HANSEN MEDICAL, INC. (Exact name of registrant as specified in its charter) Delaware 14-1850535 (State or other jurisdiction of
November 6, 2013	EX-99.1	Hansen Medical Reports Third Quarter and Nine-Month 2013 Results Third Quarter Revenue of $5.1 million Shipped Five Robotic Systems in the Quarter Commercialized Four Robotic Systems in the Quarter, and one Additional System in October, Bringing the EX-99.1 Exhibit 99.1 Hansen Medical Reports Third Quarter and Nine-Month 2013 Results Third Quarter Revenue of $5.1 million Shipped Five Robotic Systems in the Quarter Commercialized Four Robotic Systems in the Quarter, and one Additional System in October, Bringing the Year-To-Date Total to Nine Growth in Estimated Procedures Performed of 14% Quarterly, and 24% Year over Year MOUNTAIN VIEW, CA. –
November 6, 2013	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition - FORM 8-K FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES AND EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): November 6, 2013 HANSEN MEDICAL, INC.
August 26, 2013	8-K	Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Financial Statements and Exhibits, Other Events - HANSEN MEDICAL, INC. 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES AND EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): August 23, 2013 HANSEN MEDICAL, INC.
August 26, 2013	EX-99.1	HANSEN MEDICAL CLOSES AMENDED $33 MILLION INTEREST-ONLY DEBT FACILITY THROUGH 2017 AMENDED AGREEMENT INCLUDES MORE FAVORABLE TERMS FOR THE COMPANY EX-99.1 2 exh991.htm PRESS RELEASE Exhibit 99.1 HANSEN MEDICAL CLOSES AMENDED $33 MILLION INTEREST-ONLY DEBT FACILITY THROUGH 2017 AMENDED AGREEMENT INCLUDES MORE FAVORABLE TERMS FOR THE COMPANY MOUNTAIN VIEW, Calif. – August 26, 2013 – Hansen Medical, Inc. (Nasdaq: HNSN), a global leader in intravascular robotics, announced that it closed a $33 million, long-term debt agreement with White Oak Glo
August 16, 2013	SC 13D	HNSN / Hansen Medical, Inc. / SCHULER JACK W - SCHEDULE 13D Activist Investment SCHEDULE 13D SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D (Rule 13d-101) Information To Be Included in Statements Filed Pursuant to § 240.13d-1(a) and Amendments Thereto Filed Pursuant to § 240.13d-2(a) Under the Securities Exchange Act of 1934 (Amendment No. )* HANSEN MEDICAL, INC. (Name of Issuer) Common Stock, Par Value $0.0001 Per Share (Title of Class of Securities)
August 16, 2013	EX-99.4	HANSEN MEDICAL, INC. FORM OF SERIES [A][B][C] WARRANT Warrant No. [A][B][C]-[ ] Date of Issuance: [ , 2013]1 EXHIBIT 4 Exhibit 4 NEITHER THIS WARRANT, NOR THE SECURITIES ISSUABLE UPON EXERCISE OF THIS WARRANT (COLLECTIVELY, THE “SECURITIES”), HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), OR UNDER ANY STATE SECURITIES OR BLUE SKY LAWS.
August 16, 2013	EX-99.1	Joint Filing Agreement EXHIBIT 1 Exhibit 1 Joint Filing Agreement This Joint Filing Agreement is entered into as of August 15, 2013, by the undersigned, who hereby agree that the Statement on Schedule 13D with respect to the shares of the common stock, par value $0.
August 8, 2013	EX-10.1	INVESTOR RIGHTS AGREEMENT EX-10.1 2 d582149dex101.htm EX-10.1 Exhibit 10.1 INVESTOR RIGHTS AGREEMENT This INVESTOR RIGHTS AGREEMENT (the “Agreement”) is made as of August 8, 2013 by and among Hansen Medical, Inc., a corporation organized and existing under the laws of the State of Delaware (the “Company”), Oracle Partners, LP, Oracle Institutional Partners, LP and Oracle Ten Fund Master, LP (together, “Oracle”), Schuler Fa
August 8, 2013	EX-4	HANSEN MEDICAL, INC. FORM OF SERIES [A][B][C] WARRANT EX-4 3 h9999674c.htm FORM OF WARRANTS Exhibit 4 NEITHER THIS WARRANT, NOR THE SECURITIES ISSUABLE UPON EXERCISE OF THIS WARRANT (COLLECTIVELY, THE “SECURITIES”), HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), OR UNDER ANY STATE SECURITIES OR BLUE SKY LAWS. THE SECURITIES ARE SUBJECT TO RESTRICTIONS ON TRANSFERABILITY AND RESALE AND MAY NOT BE OFFERED, SOL
August 8, 2013	SC 13D	HNSN / Hansen Medical, Inc. / FEINBERG LARRY N Activist Investment SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934* Hansen Medical, Inc. (Name of Issuer) Common Stock, Par Value $0.0001 Per Share (Title of Class of Securities) 411307101 (CUSIP Number) Larry N. Feinberg c/o Oracle Investment Management, Inc. 200 Greenwich Avenue Greenwich, CT 06830 (203) 862-7900 (Name, Address and Telephone Number o
August 8, 2013	EX-99.1	Hansen Medical Announces Closing of Equity Financing Company Receives $39 Million of Initial Funds EX-99.1 Exhibit 99.1 Hansen Medical Announces Closing of Equity Financing Company Receives $39 Million of Initial Funds MOUNTAIN VIEW, CA. – August 8, 2013 – Hansen Medical, Inc. (Nasdaq: HNSN), a global leader in intravascular robotics, today announced that it has closed the private placement announced on July 31, 2013, through which approximately 28.5 million shares of the Company’s common stock
August 8, 2013	EX-1	JOINT FILING AGREEMENT EX-1 2 h9999674b.htm JOINT FILING AGREEMENT Exhibit 1 JOINT FILING AGREEMENT THIS JOINT FILING Agreement is entered into as of August 8, 2013, by and among the parties signatories hereto. The undersigned hereby agree that the Statement on Schedule 13D with respect to the shares of the common stock, par value $0.0001 per share, of Hansen Medical, Inc., a Delaware corporation, is, and any amendment
August 8, 2013	8-K	Entry into a Material Definitive Agreement, Financial Statements and Exhibits - FORM 8-K Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities and Exchange Act of 1934 Date of report (Date of earliest event reported): August 8, 2013 HANSEN MEDICAL, INC.
August 7, 2013	8-K	Results of Operations and Financial Condition - HANSEN MEDICAL, INC. 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES AND EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): August 7, 2013 HANSEN MEDICAL, INC.
August 7, 2013	EX-99.1	Hansen Medical Reports Second Quarter and Six-Month 2013 Results Company Reports 36% Increase in Quarterly Procedures and Eighth Consecutive Quarter of Procedure Growth Hansen Medical Provides Updated Outlook for Full-Year 2013 Exhibit 99.l Hansen Medical Reports Second Quarter and Six-Month 2013 Results Company Reports 36% Increase in Quarterly Procedures and Eighth Consecutive Quarter of Procedure Growth Hansen Medical Provides Updated Outlook for Full-Year 2013 MOUNTAIN VIEW, CA. – August 7, 2013 – Hansen Medical, Inc. (NASDAQ: HNSN), a global leader in intravascular robotics, today reported recent business highlights
July 31, 2013	EX-10.2	INVESTOR RIGHTS AGREEMENT EX-10.2 4 d577136dex102.htm EX-10.2 Exhibit 10.2 INVESTOR RIGHTS AGREEMENT This INVESTOR RIGHTS AGREEMENT (the “Agreement”) is made as of [—], 2013 by and among Hansen Medical, Inc., a corporation organized and existing under the laws of the State of Delaware (the “Company”), Oracle Partners, LP, Oracle Institutional Partners, LP and Oracle Ten Fund Master, LP (together, “Oracle”), Schuler Family
July 31, 2013	EX-99.1	Hansen Medical Enters into Agreement with Investors to Receive up to $93 Million in Equity Financing Company to Receive Upfront $39 Million upon Closing EX-99.1 5 d577136dex991.htm EX-99.1 Exhibit 99.1 Hansen Medical Enters into Agreement with Investors to Receive up to $93 Million in Equity Financing Company to Receive Upfront $39 Million upon Closing MOUNTAIN VIEW, CA. – July 31, 2013 – Hansen Medical, Inc. (Nasdaq: HNSN), a global leader in intravascular robotics, today announced that, subject to closing conditions, it has entered into a securi
July 31, 2013	EX-4.1	HANSEN MEDICAL, INC. FORM OF SERIES [A][B][C] WARRANT Warrant No. [A][B][C]-[ ] Date of Issuance: [ , 2013]1 EX-4.1 2 d577136dex41.htm EX-4.1 Exhibit 4.1 NEITHER THIS WARRANT, NOR THE SECURITIES ISSUABLE UPON EXERCISE OF THIS WARRANT (COLLECTIVELY, THE “SECURITIES”), HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), OR UNDER ANY STATE SECURITIES OR BLUE SKY LAWS. THE SECURITIES ARE SUBJECT TO RESTRICTIONS ON TRANSFERABILITY AND RESALE AND MAY NOT BE OFFERED, SOLD,
July 31, 2013	EX-10.1	SECURITIES PURCHASE AGREEMENT EX-10.1 3 d577136dex101.htm EX-10.1 Exhibit 10.1 EXECUTION VERSION SECURITIES PURCHASE AGREEMENT This Securities Purchase Agreement (this “Agreement”) is dated as of July 30, 2013, between Hansen Medical, Inc., a Delaware corporation (the “Company”), and each purchaser identified on Exhibit A hereto (each, including its successors and assigns, a “Purchaser” and collectively, the “Purchasers”). WHE
July 31, 2013	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits, Other Events 8-K 1 d577136d8k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities and Exchange Act of 1934 Date of report (Date of earliest event reported): July 29, 2013 HANSEN MEDICAL, INC. (Exact name of registrant as specified in charter) Delaware 001-33151 14-1850535 (State or Other Jurisdiction of Inc
July 29, 2013	8-K	Other Events - 8-K 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities and Exchange Act of 1934 Date of report (Date of earliest event reported): July 25, 2013 HANSEN MEDICAL, INC.
July 23, 2013	8-K	Termination of a Material Definitive Agreement, Financial Statements and Exhibits, Results of Operations and Financial Condition - FORM 8-K Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES AND EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): July 20, 2013 HANSEN MEDICAL, INC.
July 23, 2013	EX-99.1	Hansen Medical Reports Preliminary Second Quarter 2013 Results Commercialized Three Robotic Systems in the Quarter; Company Reports Eighth Consecutive Quarter of Procedure Growth EX-99.1 Exhibit 99.1 Hansen Medical Reports Preliminary Second Quarter 2013 Results Commercialized Three Robotic Systems in the Quarter; Company Reports Eighth Consecutive Quarter of Procedure Growth MOUNTAIN VIEW, CA. – July 23, 2013 – Hansen Medical, Inc. (NASDAQ: HNSN), a global leader in intravascular robotics, today reported certain preliminary second quarter 2013 results. Second Quarter 2013
July 17, 2013	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers - FORM 8-K Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES AND EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): July 16, 2013 HANSEN MEDICAL, INC.
July 11, 2013	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers - FORM 8-K Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES AND EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): July 8, 2013 HANSEN MEDICAL, INC.
July 10, 2013	EX-99.1	HANSEN MEDICAL TO REPLACE CURRENT DEBT FACILITY WITH NEW $33 MILLION, INTEREST-ONLY DEBT FACILITY THROUGH 2017 Will Provide Additional Liquidity of Nearly $25 Million over Next 30 Months Compared to Current Debt Facility Upon Closing and Funding of t EX-99.1 3 d566095dex991.htm EX-99.1 Exhibit 99.1 HANSEN MEDICAL TO REPLACE CURRENT DEBT FACILITY WITH NEW $33 MILLION, INTEREST-ONLY DEBT FACILITY THROUGH 2017 Will Provide Additional Liquidity of Nearly $25 Million over Next 30 Months Compared to Current Debt Facility Upon Closing and Funding of this New Debt Agreement, the Company Will Withdraw its ATM Facility which was not Drawn on or Used MOU
July 10, 2013	SC 13G/A	HNSN / Hansen Medical, Inc. / BlackRock Inc. Passive Investment SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No: 2) HANSEN MEDICAL INC. - (Name of Issuer) Common Stock - (Title of Class of Securities) 411307101 - (CUSIP Number) June 28, 2013 - (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is fi
July 10, 2013	8-K	Entry into a Material Definitive Agreement, Financial Statements and Exhibits, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Other Events - FORM 8-K Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES AND EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): July 9, 2013 HANSEN MEDICAL, INC.
July 10, 2013	EX-10.1	LOAN AND SECURITY AGREEMENT dated as of July 9, 2013 HANSEN MEDICAL, INC., as Borrower, THE ENTITIES FROM TIME TO TIME PARTY HERETO, as Lenders, WHITE OAK GLOBAL ADVISORS, LLC, as Agent TABLE OF CONTENTS Page 1. ACCOUNTING AND OTHER TERMS 1 2. LOANS EX-10.1 Exhibit 10.1 EXECUTION VERSION LOAN AND SECURITY AGREEMENT dated as of July 9, 2013 among HANSEN MEDICAL, INC., as Borrower, THE ENTITIES FROM TIME TO TIME PARTY HERETO, as Lenders, and WHITE OAK GLOBAL ADVISORS, LLC, as Agent TABLE OF CONTENTS Page 1. ACCOUNTING AND OTHER TERMS 1 2. LOANS AND TERMS OF PAYMENT 1 2.1 Promise to Pay 1 2.2 Term Loan 1 2.3 Payment of Interest on the Credit Ext
June 28, 2013	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers - FORM 8-K Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES AND EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): June 24, 2013 HANSEN MEDICAL, INC.
June 4, 2013	8-K	Submission of Matters to a Vote of Security Holders - FORM 8-K Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES AND EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): May 30, 2013 HANSEN MEDICAL, INC.
May 8, 2013	8-K	Results of Operations and Financial Condition - FORM 8-K Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES AND EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): May 8, 2013 HANSEN MEDICAL, INC.
May 8, 2013	EX-99.1	Hansen Medical Reports First Quarter 2013 Results Company Provides Updated Outlook for Full-Year 2013; Anticipating Commercialization of 14 to 17 Robotic Systems and Total Estimated Procedures of 3,100 to 3,400 Nine Clinical Magellan Systems Installe EX-99.1 Exhibit 99.1 Hansen Medical Reports First Quarter 2013 Results Company Provides Updated Outlook for Full-Year 2013; Anticipating Commercialization of 14 to 17 Robotic Systems and Total Estimated Procedures of 3,100 to 3,400 Nine Clinical Magellan Systems Installed and Performing Clinical Procedures Company Reports Record Procedures and Seventh Consecutive Quarter of Procedure Growth MOUNTA
May 8, 2013	8-K	Financial Statements and Exhibits, Other Events - FORM 8-K Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES AND EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): May 8, 2013 HANSEN MEDICAL, INC.
May 8, 2013	EX-99.1	Hansen Medical Announces Agreement in Principle to Settle Securities Class Action EX-99.1 Exhibit 99.1 Hansen Medical Announces Agreement in Principle to Settle Securities Class Action MOUNTAIN VIEW, CA. – May 8, 2013 — Hansen Medical, Inc. (NASDAQ: HNSN), a global leader in intravascular robotics, today announced that the Company has reached an agreement in principle to settle the consolidated securities class-action lawsuit related to the restatement of Hansen Medical’s finan
April 8, 2013	DEF 14A	- DEFINITIVE PROXY STATEMENT DEF 14A 1 d482829ddef14a.htm DEFINITIVE PROXY STATEMENT Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a Party other than the Registrant ¨ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confidential,
April 8, 2013	LETTER	LETTER April 8, 2013 Via E-mail Peter J. Mariani Chief Financial Officer Hansen Medical, Inc. 800 East Middlefield Road Mountainview, CA 94043 Re: Hansen Medical, Inc. Form 10-K for the Fiscal Year Ended December 31, 2011 Filed March 15, 2012 File No. 001-33151 Dear Mr. Mariani: We have completed our review of your filings. We remind you that our comments or changes to disclosure in response to our comme
March 28, 2013	PRE 14A	- PRELIMINARY PROXY STATEMENT Preliminary Proxy Statement Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.
March 28, 2013	CORRESP	- CORRESP HANSEN MEDICAL, INC. 800 E. MIDDLEFIELD ROAD MOUNTAIN VIEW, CA 94043 (650) 404 – 5800 March 28, 2013 Via Edgar Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Attention: Martin James Kate Tillan Kevin Kuhar Re: March 7, 2013 Staff Comment Letter to Hansen Medical, Inc. Concerning Form 10-K for the Fiscal Year Ended December 31, 2
March 18, 2013	S-8	- FORM S-8 S-8 1 d500840ds8.htm FORM S-8 As filed with the Securities and Exchange Commission on March 18, 2013 Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-8 REGISTRATION STATEMENT Under The Securities Act of 1933 HANSEN MEDICAL, INC. (Exact name of registrant as specified in its charter) Delaware 14-1850535 (State or other jurisdiction of incorporatio
March 18, 2013	EX-10.1	HANSEN MEDICAL, INC. Up to $25,000,000 of Shares of Common Stock (par value $0.0001 per share) Controlled Equity OfferingSM Sales Agreement EX-10.1 3 d502403dex101.htm EX-10.1 Exhibit 10.1 HANSEN MEDICAL, INC. Up to $25,000,000 of Shares of Common Stock (par value $0.0001 per share) Controlled Equity OfferingSM Sales Agreement March 15, 2013 Cantor Fitzgerald & Co. 499 Park Avenue New York, NY 10022 Ladies and Gentlemen: Hansen Medical, Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with Cantor
March 18, 2013	8-K	Entry into a Material Definitive Agreement, Financial Statements and Exhibits - FORM 8-K Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES AND EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): March 15, 2013 HANSEN MEDICAL, INC.
March 18, 2013	424B5	Up to $25,000,000 of Shares Common Stock 424B5 Table of Contents Filed Pursuant to Rule 424(b)(5) Registration No. 333-180547 PROSPECTUS SUPPLEMENT (To Prospectus dated April 23, 2012) Up to $25,000,000 of Shares Common Stock We have entered into a sales agreement with Cantor Fitzgerald & Co. relating to shares of our common stock offered by this prospectus supplement and the accompanying prospectus. In accordance with the terms of the s
March 7, 2013	LETTER	LETTER March 7, 2013 Via E-mail Peter J. Mariani Chief Financial Officer Hansen Medical, Inc. 800 East Middlefield Road Mountainview, CA 94043 Re: Hansen Medical, Inc. Form 10-K for the Fiscal Year Ended December 31, 2011 Filed March 15, 2012 Form 8-K filed February 27, 2013 File No. 001-33151 Dear Mr. Mariani: We have reviewed your response letter dated February 22, 2013 and filings and have the followi
February 27, 2013	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition - FORM 8-K Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES AND EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): February 27, 2013 HANSEN MEDICAL, INC.
February 27, 2013	EX-99.1	Hansen Medical Reports Full Year 2012 and Fourth Quarter Results Record Annual Procedures and Catheter Sales; Six Consecutive Quarters of Procedure Growth Through Q4; Over 10,000 Patients Have Now Been Treated With Intravascular Robotics Shipped Thre EX-99.1 Exhibit 99.1 Hansen Medical Reports Full Year 2012 and Fourth Quarter Results Record Annual Procedures and Catheter Sales; Six Consecutive Quarters of Procedure Growth Through Q4; Over 10,000 Patients Have Now Been Treated With Intravascular Robotics Shipped Three Robotic Systems in Q4 and three additional Robotic Systems in February 2013; At least 9 Magellan Systems Expected to be Install
February 22, 2013	CORRESP	- CORRESP HANSEN MEDICAL, INC. 800 E. MIDDLEFIELD ROAD MOUNTAIN VIEW, CA 94043 (650) 404 – 5800 February 22, 2013 Via Edgar Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Attention: Martin James Kate Tillan Kevin Kuhar Brian Soares Russ Mancuso Re: February 7, 2013 Staff Comment Letter to Hansen Medical, Inc. Concerning Form 10-K for the
February 14, 2013	SC 13G/A	HNSN / Hansen Medical, Inc. / Allianz Global Investors U.S. Holdings LLC - HANSEN MEDICAL, INC. Passive Investment OMB APPROVAL OMB Number: 3235-0145 Estimated average burden hours per response.……… 10.4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G INFORMATION STATEMENT TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULES 13d-1 (b) (c) AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2 (b) (Amendment No. 1) HANSEN MEDICAL, INC. (Name of Issuer) Common Stock (Titl
February 12, 2013	SC 13G/A	HNSN / Hansen Medical, Inc. / FEINBERG LARRY N - SC 13G/A Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G (Amendment No. 3) Under the Securities Exchange Act of 1934 Hansen Medical, Inc. (Name of Issuer) Common Stock, $0.0001 par value (Title of Class of Securities) 411307101 (CUSIP Number) December 31, 2012 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuan
February 7, 2013	LETTER	LETTER February 7, 2013 Via E-mail Peter J. Mariani Chief Financial Officer Hansen Medical, Inc. 800 East Middlefield Road Mountainview, CA 94043 Re: Hansen Medical, Inc. Form 10-K for the Fiscal Year Ended December 31, 2011 Filed March 15, 2012 Form 10-Q for the Quarter Period Ended September 30, 2012 Filed November 9, 2012 File No. 001-33151 Dear Mr. Mariani: We have reviewed your response letter dated
February 6, 2013	SC 13G/A	HNSN / Hansen Medical, Inc. / BlackRock Inc. Passive Investment SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No: 1) HANSEN MEDICAL INC. - (Name of Issuer) Common Stock - (Title of Class of Securities) 411307101 - (CUSIP Number) December 31, 2012 - (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule i
January 23, 2013	CORRESP	- Correspondence HANSEN MEDICAL, INC. 800 E. MIDDLEFIELD ROAD MOUNTAIN VIEW, CA 94043 (650) 404 – 5800 January 23, 2013 Via Edgar Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Attention: Martin James Kate Tillan Brian Soares Russ Mancuso Re: December 21, 2012 Staff Comment Letter to Hansen Medical, Inc. Concerning Form 10-K for the Fisca
December 21, 2012	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers - FORM 8-K Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES AND EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): December 11, 2012 HANSEN MEDICAL, INC.
December 21, 2012	LETTER	LETTER December 21, 2012 Via E-mail Peter J. Mariani Chief Financial Officer Hansen Medical, Inc. 800 East Middlefield Road Mountainview, CA 94043 Re: Hansen Medical, Inc. Form 10-K for the Fiscal Year Ended December 31, 2011 Filed March 15, 2012 Form 10-Q for the Quarterly Period Ended September 30, 2012 Filed November 9, 2012 File No. 001-33151 Dear Mr. Mariani: We have reviewed your filing and have th
December 12, 2012	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Other Events - FORM 8-K Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES AND EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): December 10, 2012 HANSEN MEDICAL, INC.
November 16, 2012	EX-24.TXT	EX-24.TXT rrd323641365944.html POWER OF ATTORNEY Know all by these presents, that the undersigned hereby constitutes and appoints Peter J. Mariani and Carolyn M. Bruguera, with full power of substitution, as the undersigned's true and lawful attorneys-in-fact to: (1) prepare, execute in the undersigned's name and on the undersigned's behalf, and submit to the U.S. Securities and Exchange Commission (the "SE
November 16, 2012	EX-24.TXT	EX-24.TXT rrd323645365941.html POWER OF ATTORNEY Know all by these presents, that the undersigned hereby constitutes and appoints Bruce J Barclay, Peter J. Mariani and Carolyn M. Bruguera, with full power of substitution, as the undersigned's true and lawful attorneys-in-fact to: (1) prepare, execute in the undersigned's name and on the undersigned's behalf, and submit to the U.S. Securities and Exchange Co
November 16, 2012	EX-24.TXT	EX-24.TXT rrd323644365943.html POWER OF ATTORNEY Know all by these presents, that the undersigned hereby constitutes and appoints Bruce J Barclay and Carolyn M. Bruguera, with full power of substitution, as the undersigned's true and lawful attorneys-in-fact to: (1) prepare, execute in the undersigned's name and on the undersigned's behalf, and submit to the U.S. Securities and Exchange Commission (the "SEC
November 16, 2012	EX-24.TXT	EX-24.TXT EX-24.TXT 2 rrd323649365939.htm POWER OF ATTORNEY rrd323649365939.html POWER OF ATTORNEY Know all by these presents, that the undersigned hereby constitutes and appoints Bruce J Barclay, Peter J. Mariani and Carolyn M. Bruguera, with full power of substitution, as the undersigned's true and lawful attorneys-in-fact to: (1) prepare, execute in the undersigned's name and on the undersigned's behalf,
November 16, 2012	EX-24.TXT	EX-24.TXT rrd323648365940.html POWER OF ATTORNEY Know all by these presents, that the undersigned hereby constitutes and appoints Bruce J Barclay, Peter J. Mariani and Carolyn M. Bruguera, with full power of substitution, as the undersigned's true and lawful attorneys-in-fact to: (1) prepare, execute in the undersigned's name and on the undersigned's behalf, and submit to the U.S. Securities and Exchange Co
November 13, 2012	SC 13G/A	HNSN / Hansen Medical, Inc. / ARASKOG RAND V - SC 13G/A Passive Investment SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G/A (Rule 13d-102) Under the Securities Exchange Act of 1934 (Amendment No. 2) Hansen Medical, Inc. (Name of Issuer) Common Stock (Title of Class of Securities) 411307101 (CUSIP Number) November 13, 2012 (1) (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which t
November 7, 2012	EX-99.1	Hansen Medical Reports Third Quarter and Nine-Month 2012 Results Magellan™ Robotic Systems Installed at Three Leading U.S. Hospitals Two Successful Live Magellan System Cases Presented by Dr. Barry Katzen at Transcatheter Cardiovascular Therapeutics Press Release Exhibit 99.1 Hansen Medical Reports Third Quarter and Nine-Month 2012 Results Magellan™ Robotic Systems Installed at Three Leading U.S. Hospitals Two Successful Live Magellan System Cases Presented by Dr. Barry Katzen at Transcatheter Cardiovascular Therapeutics (TCT) Conference Received $30 Million from Expanded Agreement with Intuitive Surgical MOUNTAIN VIEW, CA. – November 7, 2012
November 7, 2012	SC 13G	HNSN / Hansen Medical, Inc. / INTUITIVE SURGICAL INC - SCHEDULE 13G Passive Investment Schedule 13G SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G* (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULES 13d-1(b), (c), AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2 (Amendment No. )* HANSEN MEDICAL, INC. (Name of Issuer) Common Stock, $0.0001 par value per share (Title of Class of Securities) 411307101 (CUSIP Number) Octobe
November 7, 2012	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition - FORM 8-K Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES AND EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): November 7, 2012 HANSEN MEDICAL, INC.
October 31, 2012	8-K	Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits - FORM 8-K Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities and Exchange Act of 1934 Date of report (Date of earliest event reported): October 26, 2012 HANSEN MEDICAL, INC.
October 31, 2012	EX-99.1	Hansen Medical Announces Expanded Agreement with Intuitive Surgical Intuitive Surgical to Pay $20 Million to Acquire an Extended License to Certain Patents in Hansen Medical’s Patent Portfolio and Purchase $10 Million of Hansen Medical Stock Press Release Exhibit 99.1 Hansen Medical Announces Expanded Agreement with Intuitive Surgical Intuitive Surgical to Pay $20 Million to Acquire an Extended License to Certain Patents in Hansen Medical’s Patent Portfolio and Purchase $10 Million of Hansen Medical Stock MOUNTAIN VIEW, CA. – October 31, 2012 – Hansen Medical, Inc. (Nasdaq: HNSN), a global leader in intravascular robotics, today annou
August 17, 2012	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers - FORM 8-K Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES AND EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): August 13, 2012 HANSEN MEDICAL, INC.
August 8, 2012	EX-99.1	Hansen Medical Reports Second Quarter and Six-Month 2012 Results Strong and Growing US Magellan Clinical Interest Following June FDA Clearance; Company Announces Realignment of Resources to Focus on Magellan Commercialization EX-99.1 2 d393940dex991.htm PRESS RELEASE Exhibit 99.1 Hansen Medical Reports Second Quarter and Six-Month 2012 Results Strong and Growing US Magellan Clinical Interest Following June FDA Clearance; Company Announces Realignment of Resources to Focus on Magellan Commercialization MOUNTAIN VIEW, CA. – August 8, 2012 – Hansen Medical, Inc. (NASDAQ: HNSN), a global leader in intravascular robotics, t
August 8, 2012	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition - FORM 8-K Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES AND EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): August 8, 2012 HANSEN MEDICAL, INC.
July 25, 2012	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Other Events - FORM 8-K FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES AND EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): July 25, 2012 HANSEN MEDICAL, INC.
June 15, 2012	SC 13G/A	HNSN / Hansen Medical, Inc. / SCHULER JACK W - SCHEDULE 13G AMENDMENT NO. 3 Passive Investment SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO ? 240.13d-1(b), (c) AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO ? 240.13d-2 Under the Securities Exchange Act of 1934 (Amendment No. 3)* Hansen Medical, Inc. (Name of Issuer) Common Shares, no par value (Title of Class of Securities) 411307101 (CUSIP
June 4, 2012	8-K	Financial Statements and Exhibits, Other Events - FORM 8-K Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES AND EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): June 4, 2012 HANSEN MEDICAL, INC.
June 4, 2012	EX-99.1	Hansen Medical Receives FDA 510(k) Clearance for its Magellan™ Robotic System for Peripheral Vascular Interventions Company to Commence Initial Commercial Launch in the United States Immediately Hansen Medical to Host Conference Call Today at 2:00 PM Press Release Exhibit 99.1 Hansen Medical Receives FDA 510(k) Clearance for its Magellan™ Robotic System for Peripheral Vascular Interventions Company to Commence Initial Commercial Launch in the United States Immediately Hansen Medical to Host Conference Call Today at 2:00 PM PT MOUNTAIN VIEW, CA. – June 4, 2012 – Hansen Medical, Inc. (Nasdaq: HNSN), a global leader in intravascular robotics and
June 1, 2012	8-K	Submission of Matters to a Vote of Security Holders - FORM 8-K Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES AND EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): May 25, 2012 HANSEN MEDICAL, INC.
May 2, 2012	EX-99.1	HANSEN MEDICAL REPORTS FIRST QUARTER 2012 RESULTS Still Anticipating Second Quarter 2012 510(k) Clearance and U.S. Launch of Magellan™ Robotic System Press Release Exhibit 99.1 HANSEN MEDICAL REPORTS FIRST QUARTER 2012 RESULTS Still Anticipating Second Quarter 2012 510(k) Clearance and U.S. Launch of Magellan™ Robotic System MOUNTAIN VIEW, CA. – May 2, 2012 – Hansen Medical, Inc. (Nasdaq: HNSN), a global leader in flexible medical robotics and the developer of robotic technology for accurate 3D control of catheter movement, today reported recen
May 2, 2012	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition - FORM 8-K Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES AND EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): May 2, 2012 HANSEN MEDICAL, INC.
April 16, 2012	CT ORDER	- begin 644 filename1.pdf M)5!$1BTQ+C4-)>+CS],-"C0T(#`@;V)J#3P\+TQI;F5AF4@-38F!@8&%@8(IF``(>$094P,@` MDN5H0!9C@6(&AAL,W`Q<3%]9%D"5RKI":89,6&S!!11CV```,`XR`$Y0T* M96YD7!E+U!A9V4^/@UE;F1O8FH-#<@,"!O8FH-/#PO1FEL=&5R+T9L871E M1&5C;V1E+T9I<&4O3V)J4W1M/CYS M=')E86T-"FC>U);=:]LP$,#%3UN#T4?EBP;2J')%E;8RFC".BA]\!3&![ MV"Y;O=G2U9<9-TR\O8P]6R[L-WI],O-9()9A23"3,14P9>-)-:&68,D[&V M[('?3>3K,E73=@?/=X>MDP*%?
April 10, 2012	8-K	Other Events Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES AND EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): April 10, 2012 HANSEN MEDICAL, INC.
April 3, 2012	S-3	- FORM S-3 S-3 1 d325773ds3.htm FORM S-3 Table of Contents As filed with the Securities and Exchange Commission on April 3, 2012. Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM S-3 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 HANSEN MEDICAL, INC. (Exact name of registrant as specified in its charter) Delaware 14-1850535 (State or other jurisdiction
April 3, 2012	EX-4.1	HANSEN MEDICAL, INC. [ ] Dated as of [ ], 20[ ] HANSEN MEDICAL, INC. Reconciliation and tie between Trust Indenture Act of 1939 and Indenture, dated as of [ ], 20[ ] Trust Indenture Act Section Indenture Sections § 310(a)(1) 6.09 (a)(2) 6.09 (a)(3) N EX-4.1 2 d325773dex41.htm FORM OF INDENTURE RELATED TO DEBT SECURITIES Exhibit 4.1 HANSEN MEDICAL, INC. [ ] Trustee Indenture Dated as of [ ], 20[ ] HANSEN MEDICAL, INC. Reconciliation and tie between Trust Indenture Act of 1939 and Indenture, dated as of [ ], 20[ ] Trust Indenture Act Section Indenture Sections § 310(a)(1) 6.09 (a)(2) 6.09 (a)(3) Not Applicable (a)(4) Not Applicable (a)(5) 6.09 (
April 3, 2012	EX-12.1	HANSEN MEDICAL INC. COMPUTATION OF RATIO OF EARNINGS TO FIXED CHARGES Year Ended December 31 2007 2008 2009 2010 2011 Earnings available to cover fixed charges: Income/(Loss) from continuing operation before income taxes $ (50,859 ) $ (57,868 ) $ (52 Computation of Ratio of Earnings to Fixed Charges Exhibit 12.1 HANSEN MEDICAL INC. COMPUTATION OF RATIO OF EARNINGS TO FIXED CHARGES Year Ended December 31 2007 2008 2009 2010 2011 Earnings available to cover fixed charges: Income/(Loss) from continuing operation before income taxes $ (50,859 ) $ (57,868 ) $ (52,449 ) $ (37,895 ) $ (16,712 ) Plus: Fixed charges, as below $ 652 $ 1,540 $ 1,805 $ 1,
April 3, 2012	424B3	HANSEN MEDICAL, INC. 4,784,690 Shares of Common Stock Pursuant to 424(b)(3) Registration No. 333-178930 Table of Contents PROSPECTUS Filed Pursuant to Rule 424(b)(3) Registration No. 333-178930 HANSEN MEDICAL, INC. 4,784,690 Shares of Common Stock This prospectus relates to the offer for sale by the existing holders of our common stock named in this prospectus of 4,784,690 shares of our common stock, par value $0.0001 per share. These existing holder
March 30, 2012	DEF 14A	- DEFINITIVE PROXY STATEMENT DEF 14A 1 d323373ddef14a.htm DEFINITIVE PROXY STATEMENT Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a Party other than the Registrant ¨ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confidential,
March 28, 2012	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers - FORM 8-K Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES AND EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): March 27, 2012 HANSEN MEDICAL, INC.
March 26, 2012	SC 13G/A	HNSN / Hansen Medical, Inc. / SCHULER JACK W - SC 13G/A Passive Investment SC 13G/A SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 2)* Hansen Medical, Inc. (Name of Issuer) Common Shares, no par value (Title of Class of Securities) 411307101 (CUSIP Number) March 15, 2012 (Date of Event Which Requires Filing of This Statement) Check the appropriate box to designate the rule pursuant to which
March 2, 2012	EX-24.	- MACKINNON POA rrd301899340655.html POWER OF ATTORNEY Know all by these presents, that the undersigned hereby constitutes and appoints Peter J. Mariani and Carolyn M. Bruguera, with full power of substitution, as the undersigned's true and lawful attorneys-in-fact to: (1) prepare, execute in the undersigned's name and on the undersigned's behalf, and submit to the U.S. Securities and Exchange Commission (the "SE
February 28, 2012	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers - FORM 8-K Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES AND EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): February 25, 2012 HANSEN MEDICAL, INC.
February 22, 2012	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition - FORM 8-K Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES AND EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): February 22, 2012 HANSEN MEDICAL, INC.
February 22, 2012	EX-99.1	HANSEN MEDICAL REPORTS FOURTH QUARTER AND FULL YEAR 2011 Press Release Exhibit 99.1 HANSEN MEDICAL REPORTS FOURTH QUARTER AND FULL YEAR 2011 RESULTS Shipped 6 Robotic Systems in Fourth Quarter Delivered Annual Records for Both Procedures and Catheter Sales Submitted response to FDA for the Magellan Robotic System; Anticipate Second Quarter 2012 Clearance and Commercial Launch MOUNTAIN VIEW, CA. – February 22, 2012 – Hansen Medical, Inc. (Nasdaq: HNSN),
February 14, 2012	SC 13G/A	HNSN / Hansen Medical, Inc. / ARTIS CAPITAL MANAGEMENT, L.P. - SC 13G/A AMENDMENT NO 1 FOR ARTIS CAPITAL MANAGEMENT - HANSEN MEDICAL, INC. Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1) Hansen Medical, Inc. (Name of Issuer) Common Stock, par value $0.0001 per share (Title of Class of Securities) 411307101 (CUSIP Number) December 31, 2011 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the ru
February 13, 2012	SC 13G	HNSN / Hansen Medical, Inc. / Allianz Global Investors U.S. LLC - SC 13G Passive Investment SC 13G OMB APPROVAL OMB Number: 3235-0145 Estimated average burden hours per response ………… 10.
February 9, 2012	SC 13G	HNSN / Hansen Medical, Inc. / BlackRock Inc. Passive Investment SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No: ) HANSEN MEDICAL INC - (Name of Issuer) Common Stock - (Title of Class of Securities) 411307101 - (CUSIP Number) December 30, 2011 - (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is
February 3, 2012	EX-99.1	SUPERIOR COURT OF THE STATE OF CALIFORNIA COUNTY OF SANTA CLARA IN RE HANSEN MEDICAL, INC. ) Lead Case No. 1:09-CV-157170 SHAREHOLDER DERIVATIVE ) LITIGATION ) (Consolidated with Case No. 1:09-CV-157592) ) This Document Relates To: ) NOTICE OF PENDEN Notice of Pendency and Proposed Settlement of Shareholder Derivative Actions. Exhibit 99.1 ROBBINS UMEDA LLP BRIAN J. ROBBINS (190264) KEVIN A. SEELY(199982) CHRISTOPHER L. WALTERS (205510) ASHLEY R. PALMER (246602) 600 B Street, Suite 1900 San Diego, CA 92101 Telephone: (619) 525-3990 Facsimile: (619) 525-3991 Lead Counsel for Plaintiffs SUPERIOR COURT OF THE STATE OF CALIFORNIA COUNTY OF SANTA C
February 3, 2012	8-K	Financial Statements and Exhibits, Other Events - FORM 8-K Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES AND EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): January 27, 2012 HANSEN MEDICAL, INC.
January 30, 2012	SC 13G/A	HNSN / Hansen Medical, Inc. / SCHULER JACK W - SCHEDULE 13G AMENDMENT NO. 1 Passive Investment Schedule 13G Amendment No. 1 SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1)* Hansen Medical, Inc. (Name of Issuer) Common Shares, no par value (Title of Class of Securities) 411307101 (CUSIP Number) January 19, 2012 (Date of Event Which Requires Filing of This Statement) Check the appropriate box to designate the r
January 25, 2012	SC 13G/A	HNSN / Hansen Medical, Inc. / FEINBERG LARRY N - AMENDMENT TO SCHEDULE 13G Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G (Amendment No. 1) Under the Securities Exchange Act of 1934 Hansen Medical, Inc. (Name of Issuer) Common Stock, $0.0001 par value (Title of Class of Securities) 411307101 (CUSIP Number) December 31, 2011 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuan
January 25, 2012	SC 13G/A	HNSN / Hansen Medical, Inc. / FEINBERG LARRY N - FORM SC 13G/A Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G (Amendment No. 2) Under the Securities Exchange Act of 1934 Hansen Medical, Inc. (Name of Issuer) Common Stock, $0.0001 par value (Title of Class of Securities) 411307101 (CUSIP Number) January 19, 2012 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant

HNSN / Hansen Medical, Inc. - Arquivamentos da SEC, Relatório Anual, Declaração de Procuração

Estatísticas Básicas

SEC Filings

SEC Filings (Chronological Order)

How Much do you Like Fintel?

Write a Review and get 25% Off Your Next Purchase

How can we Improve?